July 20, 2023 Acute Rejection After Kidney Transplant—An Endpoint Not Predictive of Treatment Effect on Graft Survival
July 20, 2023 TTC Announces Publication in Transplantation C-Path’s Transplant Therapeutics Consortium is pleased to announce the recent publication in Transplantation by William Fit
July 19, 2023 FDA Draft Controls Guidance: A Roundtable Discussion Please join C-Path and the Clinical Research Data Sharing Alliance (CRDSA) on Wednesday, July 19, at from 10:00 a.m. to noon EDT f
July 19, 2023 The Foundation for Angelman Syndrome Therapeutics to Contribute Data to C-Path’s RDCA-DAP, Accelerating Neurological Disease Research and Therapeutic Development TUCSON, Ariz., July 19, 2023 — Critical Path Institute (C-Path) announced today that the Foundation for Angelman Syndrome Therap
July 18, 2023 C-Path Integrates European Offices to Optimize Global Operations and Collaborative Partnerships AMSTERDAM and TUCSON, Ariz., July 18, 2023 — Critical Path Institute (C-Path) announced today the completion of the integration
July 13, 2023 C-Path and Vivpro Formalize Partnership to Accelerate Drug Development The strategic collaboration between C-Path and Vivpro seeks to leverage Vivpro’s innovative biointelligence platform, foster
July 13, 2023 Diagnostic capacities and treatment practices on implantation mycoses: Results from the 2022 WHO global online survey Between January and March 2022, WHO conducted a global online survey to collect data on diagnostic capacities and treatment...
July 13, 2023 Drug Repurposing for Pandemic Innovation: Establishing an Effective and Efficient Ecosystem Effective treatments for both existing and emerging diseases may already be available on pharmacy shelves. Many approved drugs...
July 12, 2023 Sanford Health Rare Disease Data Registry Partners with C-Path’s RDCA-DAP, Cure Mito Foundation to Aggregate Rare Disease Data in Platform TUCSON, Ariz., July 12, 2023 — Critical Path Institute (C-Path) announced today that the Coordination of Rare Diseases based at
July 6, 2023 Multistakeholder Collaborations Are Vital to Advancing Technologies in Parkinson’s TUCSON, Ariz., July 6, 2023 — Critical Path Institute (C-Path) and the Center for Health + Technology (CHeT) at University of Ro